Shan Ping Yu | Translational Neuroscience | Innovative Research Award

Innovative Research Award

Shan Ping Yu, 
Emory University School of Medicine, Atlanta, Georgia, United States

Shan Ping Yu
Affiliation Emory University School of Medicine
Country United States
Scopus ID 36157350300
Documents 194
Citations 14,194
h-index 62
Subject Area Neuroscience, Stroke Research, Stem Cell Biology, Neurodegeneration, Translational Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0003-1335-1398

Shan Ping Yu, is an internationally recognized neuroscientist and physician-scientist affiliated with the Department of Anesthesiology at Emory University School of Medicine. His research career spans several decades and encompasses fundamental and translational investigations in neuroprotection, stroke biology, stem cell therapeutics, ion channel regulation, neurodegenerative disorders, and cellular signaling mechanisms. Through leadership in academic medicine, editorial service, grant review activities, and mentorship, Yu has contributed substantially to contemporary neuroscience research and regenerative medicine initiatives.[1]

Abstract

This academic article examines the professional achievements and scientific contributions of Shan Ping Yu, MD/PhD, whose multidisciplinary research has significantly influenced the fields of neuroscience, neurodegenerative disease biology, stroke pathology, and regenerative medicine. Yu’s investigations into ion channel signaling, neural cell death mechanisms, stem cell therapeutics, and neuroinflammation have contributed to improved understanding of brain injury and neural repair processes. His leadership roles at Emory University and multiple international scientific organizations reflect sustained engagement in advancing translational neuroscience research. The article further evaluates Yu’s publication record, editorial leadership, peer-review service, mentoring activities, and global academic collaborations in the context of scientific recognition and award suitability.[2]

Keywords

  • Neuroscience
  • Stroke Research
  • Neurodegeneration
  • Stem Cell Therapy
  • Ion Channels
  • Cell Death Mechanisms
  • Regenerative Medicine
  • Brain Injury
  • Translational Neuroscience
  • Neural Repair

Introduction

The advancement of neuroscience and neurodegenerative disease research relies heavily on interdisciplinary approaches integrating molecular biology, pharmacology, stem cell science, and translational medicine. Shan Ping Yu has contributed to these developments through extensive investigations into ischemic brain injury, neuronal cell death, neuroprotection, and stem cell-mediated recovery pathways. His scientific career spans academic appointments at Washington University, the Medical University of South Carolina, and Emory University, where he currently serves as Asa Griggs Candler Endowed Professor with tenure.[1]

Yu’s work has also emphasized the clinical relevance of molecular neuroscience discoveries, particularly in relation to stroke, traumatic brain injury, and Alzheimer’s disease research. His studies on ion channels and neuroinflammation have contributed to broader understanding of neuronal survival and regenerative signaling mechanisms.[3]

Research Profile

Shan Ping Yu obtained his MD and MS degrees from the Capital Institute of Medicine in Beijing, China, followed by a PhD from the State University of New York at Stony Brook. His postdoctoral training at the Howard Hughes Medical Institute further strengthened his expertise in neurobiology and cellular signaling mechanisms. Yu later established an internationally recognized research program focused on ischemic brain injury and neuroregeneration.[4]

At Emory University School of Medicine, Yu has led multidisciplinary projects examining molecular pathways involved in neuronal injury and neural repair. His research integrates experimental neuroscience with translational therapeutic development, particularly in stem cell-based interventions and neuroprotective pharmacology.[5]

Research Contributions

Yu has contributed substantially to the understanding of neuronal apoptosis, necrosis, oxidative stress signaling, and ionic dysregulation during cerebral ischemia. His investigations into potassium and calcium channel modulation in neuronal injury have influenced experimental stroke therapeutics and neuroprotective strategies.[5]

Another major area of contribution involves stem cell therapy for neurological disorders. Yu’s collaborative studies explored mechanisms by which stem cells facilitate neural repair and functional recovery following stroke and traumatic brain injury. These investigations have informed broader regenerative medicine strategies aimed at restoring neural circuitry after injury.[4]

Publications

Yu’s publication portfolio includes numerous peer-reviewed articles in neuroscience, pharmacology, neurochemistry, and regenerative medicine journals. His work has appeared in internationally recognized journals including Stroke, Journal of Neuroscience, PNAS, Cell Death & Disease, and Translational Stroke Research.[2]

Research Impact

Yu’s scientific impact extends across neuroscience, regenerative medicine, and translational stroke research communities. His participation in NIH, NSF, VA, and international grant review panels demonstrates recognition as an authority in neurobiology and neurological disease research. He has also supervised postdoctoral fellows and junior investigators who subsequently obtained faculty appointments and research leadership positions internationally.[1]

His mentorship activities and commitment to diversity and inclusion in STEM education have contributed to career advancement opportunities for minority scholars and international researchers. Yu’s involvement with the PATHs AGEP Alliance and mentorship of early-career investigators highlights sustained contributions to academic workforce development.[2]

Award Suitability

Shan Ping Yu’s research career demonstrates sustained excellence in neuroscience and neurodegenerative disease investigation. His extensive publication record, international scientific collaborations, editorial leadership, conference organization, grant review participation, and mentoring contributions collectively support recognition within advanced scientific award categories. His work has influenced both experimental neuroscience research and translational therapeutic development in stroke and neurodegeneration.[2]

The breadth of Yu’s contributions across academia, research administration, and scientific mentorship aligns strongly with criteria commonly associated with lifetime achievement, excellence in neuroscience research, and translational medicine awards.[3]

Conclusion

Shan Ping Yu, MD/PhD, has established a distinguished international reputation in neuroscience and regenerative medicine through decades of scholarly achievement, translational research, and scientific leadership. His work in neuroprotection, stem cell therapy, neurodegeneration, and stroke biology has contributed to improved understanding of neurological disease mechanisms and therapeutic strategies. Through mentorship, peer-review service, conference organization, and editorial activities, Yu has also strengthened global neuroscience research networks and academic training initiatives.[4]

References

  1. Emory University School of Medicine. (2025). Faculty Curriculum Vitae: Shan Ping Yu, MD/PhD.
  2. Elsevier. (n.d.). Scopus author details: Shan Ping Yu, Author ID 36157350300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36157350300
  3. ScienceDaily. (2021). Alternative model of Alzheimer’s emphasizes different mechanisms leading to neurodegeneration.
  4. State University of New York at Stony Brook. Postdoctoral and doctoral research records related to neuroscience training.
  5. Emory University School of Medicine. Department of Anesthesiology faculty profile and research overview.

Xufeng Huang | Neuroscience of Obesity and Schizophrenia | Neuroscience Academic Excellence Award

Prof. Dr. Xufeng Huang | Neuroscience of Obesity and Schizophrenia | Neuroscience Academic Excellence Award

University of Wollongong | Australia

Professor Xufeng Huang is an internationally recognised molecular neuroscientist whose research integrates brain biology, metabolism, psychopharmacology, and nutritional science to address major public health challenges. His work has elucidated central molecular mechanisms of diet-induced obesity, including leptin resistance, neural injury, and cognitive decline, and translated these discoveries into preventive and therapeutic strategies. He has led pioneering research on antipsychotic-induced metabolic disorders in schizophrenia, identifying key neurotransmitter and receptor pathways and advancing safer pharmacological and adjunctive interventions. Professor Huang has also driven innovation in functional nutrition, notably the discovery and clinical validation of β-glucan as an effective dietary fibre for metabolic syndrome control, influencing dietary guidelines and policy. With extensive leadership of NHMRC-funded programs and international collaborations, his research spans mechanistic discovery, animal and human studies, and clinical translation. His contributions have shaped evidence-based interventions in brain health, obesity, metabolic disease, and severe mental illness, with sustained impact on clinical practice, policy development, and translational research across Australia and internationally.

Citation Metrics (Scopus)

16000
10000
6000
1000
0

Citations
14,714

Documents
349

h-index
66

Citations

Documents

h-index

View Scopus Profile View ORCID Profile View Google Scholar Profile

Featured Publications

Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice
– S Lin, TC Thomas, LH Storlien, XF Huang, International Journal of Obesity, 2000

Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression
– H Wang, LH Storlien, XF Huang, American Journal of Physiology–Endocrinology and Metabolism, 2002

Selective antagonist [3H] SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia
– K Zavitsanou, T Garrick, XF Huang, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2004

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
– CS Weickert, SJ Fung et al., Molecular Psychiatry, 2013

Nicole Goff | Neuroscience | Excellence in Research Award

Ms. Nicole Goff | Neuroscience | Excellence in Research Award

MedStar Franklin Square Hospital | United States

Nicole Goff, MSN, RN, is an experienced stroke program navigator and emerging nurse scientist whose research focuses on improving acute stroke identification, response efficiency, and patient outcomes across the continuum of care. Her scholarly work centers on strengthening pre-hospital and in-hospital stroke systems through nurse-led interventions, data-driven quality improvement, and interprofessional collaboration. Nicole has contributed to research on temporal trends in code stroke utilization and the evolving need for mechanical thrombectomy in acute ischemic stroke, offering insights that support resource allocation and workflow optimization in high-acuity settings. She is also involved in evaluating the clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy across MedStar Health, advancing personalized medicine and precision pharmacotherapy in stroke care. Her first peer-reviewed publication, a feasibility pilot study published in the Journal of Radiology Nursing, assessed a nurse-led BEFAST-based training program for police officers to improve early identification of stroke versus stroke mimics, addressing a critical gap in community-level stroke recognition. Nicole has presented her findings at state, national, and international nursing conferences, highlighting innovations in door-to-needle time reduction, mechanical thrombectomy outcomes, and nurse-led stroke response models. Her research reflects a commitment to improving neurologic emergency care through education, evidence-based practice, and system-level change.

Profile: Scopus

Featured Publication

DeRita, N., Schwenk, K., Sims, H., Singh, P., & Woodward, A. (2025). A nurse-led, BEFAST-based training for police officers to improve pre-hospital stroke vs. stroke mimic identification: A pilot feasibility study. Journal of Radiology Nursing.